Pharmacogenomics of statins: understanding susceptibility to adverse effects
about
Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.Genetics of Sex Hormone-Binding Globulin and Testosterone Levels in Fertile and Infertile Men of Reproductive Age.Lipid Screening, Action, and Follow-up in Children and AdolescentsInteractions Between Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
P2860
Pharmacogenomics of statins: understanding susceptibility to adverse effects
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@ast
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@en
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@nl
type
label
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@ast
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@en
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@nl
prefLabel
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@ast
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@en
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@nl
P2093
P2860
P3181
P356
P1476
Pharmacogenomics of statins: understanding susceptibility to adverse effects
@en
P2093
Anees Dauki
Chandrama Mukherjee
Eduard Mikulik
Jasmine Luzum
Joseph Kitzmiller
P2860
P304
P3181
P356
10.2147/PGPM.S86013
P407
P577
2016-10-03T00:00:00Z